
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated September 27, 2024, titled "Zydus and CSIR-Central Drug Research Institute Lucknow to develop best-in-class drug for Chronic Kidney Disease induced Osteoporosis".
Filed with NSE ·

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated September 27, 2024, titled "Zydus and CSIR-Central Drug Research Institute Lucknow to develop best-in-class drug for Chronic Kidney Disease induced Osteoporosis".
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences